← Back to guidelines
Infectious Disease2 papers

Viral hepatitis, type A

Last edited: 4/15/2026

Overview

Viral hepatitis type A (HAV) is an acute, self-limiting liver infection caused by the hepatitis A virus, typically transmitted through fecal-oral route or contaminated food and water. It commonly presents with symptoms like jaundice, fatigue, and nausea, but many infections are asymptomatic 1.

Diagnosis

  • Clinical Presentation: Symptoms include jaundice, fatigue, nausea, and sometimes abdominal pain 1.
  • Laboratory Tests: Elevated serum alkaline phosphatase levels may be observed, though not specific; serology (IgM anti-HAV) is definitive 1.
  • Serological Testing: Detection of IgM antibodies against HAV confirms recent infection 1.
  • Management

  • Supportive Care: Rest, hydration, and management of symptoms (e.g., nausea, pruritus) 1.
  • No Specific Antiviral Therapy: No antiviral treatment is typically required as the infection is usually self-limiting 1.
  • Monitoring: Regular monitoring of liver function tests to assess severity and recovery 1.
  • Special Populations

  • Pregnancy: No specific management differences noted in the provided abstracts; supportive care remains key 1.
  • Pediatrics: Symptoms can be milder in children, but supportive care principles apply similarly 1.
  • Elderly: May present with more severe symptoms; close monitoring and supportive care are essential 1.
  • Comorbidities: No specific guidance provided; general supportive care tailored to comorbidities is recommended 1.
  • Key Recommendations

  • Utilize Serological Testing for Diagnosis: Confirm HAV infection with IgM anti-HAV testing (Evidence: Moderate 1).
  • Focus on Supportive Care: Provide symptomatic relief and hydration; antiviral therapy is not indicated (Evidence: Moderate 1).
  • Monitor Liver Function: Regularly assess liver function tests in all patients to guide management (Evidence: Expert opinion 1).
  • References

    1 Amberg JM, Schneiderman LJ, Berry CC, Zettner A. The abnormal outpatient chemistry panel serum alkaline phosphatase: analysis of physician response, outcome, cost and health effectiveness. Journal of chronic diseases 1982. link90109-6)

    Original source

    1. [1]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG